Titre :
  • Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.
Auteur : Pestalozzi, B C ; Francis, P ; Quinaux, E ; Dolci, Stella ; Azambuja, Evandro ; Gelber, R D ; Viale, G ; Balil, A ; Andersson, M ; Nordenskjöld, B ; Gnant, Michael ; Gutierrez, J ; Láng, I ; Crown, J P A ; Piccart-Gebhart, Martine ; BIG 02-98 Collaborative Group
Informations sur la publication : Annals of oncology, 19, 11, (page 1837-1841)
Statut de publication : Publié, 2008-11
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Adjuvant chemotherapy
Breast cancer
Central nervous system
Meningeal carcinomatosis
Taxane
Trastuzumab
Mots-clés MeSH : Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- cerebrospinal fluid
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Central Nervous System Neoplasms -- cerebrospinal fluid
Central Nervous System Neoplasms -- secondary
Chemotherapy, Adjuvant
Cyclophosphamide -- administration & dosage
Doxorubicin -- administration & dosage
Female
Fluorouracil -- administration & dosage
Humans
Methotrexate -- administration & dosage
Middle Aged
Neoplasm Metastasis
Taxoids -- administration & dosage
Taxoids -- adverse effects
Treatment Failure
Note : Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdn385
info:pii/mdn385
info:pmid/18562328
info:pmcid/PMC2733076